Global Infertility Diagnostics Devices Patent Landscape Report 2024

Global Infertility Diagnostics Devices Market Size

The infertility diagnostics devices market was valued at USD 1.18 billion in 2023. It is expected to grow at a CAGR of 8.8% during the forecast period of 2024-2032 and attain a market value of USD 2.52 billion in 2032.

There has been a significant increase in the number of patent applications associated with infertility diagnostics devices and the market is driven by rising rates of infertility worldwide, which are caused by delayed parenthood, lifestyle changes, and environmental influences.

Patent Landscape Report Coverage

The Global Infertility Diagnostics Devices Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for global infertility diagnostics devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within infertility diagnostic device technologies.

High-resolution ultrasound and cutting-edge imaging technologies like 3D and 4D ultrasounds help detect conditions like fibroids and polycystic ovary syndrome (PCOS) by providing detailed images of the uterus, fallopian tubes, and ovaries. Therefore, such techniques have a significant impact on the patent landscape.

Global Infertility Diagnostics Devices Patent Outlook

• Infertility diagnostic devices are becoming more inventive, and adaptable, intended to provide increased efficacy by technological advancements like enhanced imaging systems, more precise ovulation prediction kits, and sophisticated sperm analysis systems.

• The market growth is boosted by rising public acceptance and awareness of infertility diagnostics and treatments, which is supported by media coverage and educational initiatives.

• The market is stimulated by supportive government policies and initiatives that aim to improve access to infertility treatments and reproductive health. It includes subsidies for medical equipment as well as financing schemes.

What are Infertility Diagnostic Devices?

Medical instruments like infertility diagnostics devices  are used to determine and assess the underlying causes of infertility in both men and women. By offering comprehensive insights into the structural, hormonal, and genetic factors that may contribute to infertility, they play a critical role in evaluating reproductive health and enabling individualized and successful treatment plans. These tools, which support precise infertility diagnosis and treatment planning, include imaging systems, prediction kits, and other testing technologies.

The infertility diagnostics devices market continues to evolve as societal trends that favor delaying parenthood for personal and professional reasons are becoming common. This has resulted in an increased incidence of infertility which raises the need for diagnostic tools. Also, the growing and strengthening of the healthcare infrastructures in developing nations makes infertility diagnostics more accessible, which propels market expansion significantly.

Infertility Diagnostics Devices Industry Growth Drivers

Increasing Product Launches is Expected to Boost the Market Growth

The infertility diagnostic devices patent landscape is driven by the increasing number of new product launches. This pattern is the result of the industry's continuous investment in R&D, which satisfies the expanding need for advanced diagnostic services. New products developed using innovative technologies prompt the manufacturers to file for patent applications and secure their technologies to assert market dominance. The accuracy and effectiveness of infertility assessments are improved by ongoing innovations and the introduction of cutting-edge diagnostic tools, which facilitate the diagnosis and successful treatment of infertility problems by medical professionals.

Growing Awareness and Acceptance is Expected to Propel the Infertility Diagnostic Devices Patent Industry

Market expansion has been greatly aided by rising public acceptance of infertility diagnostics and treatments. Increased societal acceptance, media attention, and educational initiatives are motivating more people and couples to seek infertility diagnoses and treatments.

With the increasing acceptance and innovation in technology, there has been an increase in patent grants rising from 225 patents in 2022 to 258 patents in 2023.

Global Infertility Diagnostics Devices Patent Segmentation

The report provides an in-depth analysis of the patents in this field by the following segmentation - 

Breakup by Product Type

• Imaging Systems  
  • Ultrasound
  • MRI Systems
  • Others

• Ovulation Prediction Kits

• Sperm Analysis Systems

• Others

Breakup by Test Type

• Female Infertility Testing
  • Ovarian Reserve Testing      
  • Hormonal Level Testing
  • Tubal Patency Test
  • Others

• Male Infertility Testing
  • Semen Analysis
  • DNA Fragmentation
  • Other Sperm Function Test

Infertility Diagnostics Devices Patent Segmentation Analysis

The breakup based on product type is broadly divided into imaging systems, ovulation prediction kits, sperm analysis systems and others. Imaging systems are further divided into ultrasound, MRI systems and others.

Ovulation prediction kits study the spike in luteinizing hormone (LH) in the urine that happens just before ovulation. This spike in hormones helps women plan when to undergo insemination to increase their chances of getting pregnant by indicating the most fertile days in their menstrual cycle. These kits are vital resources for reproductive health because they offer a precise and non-invasive way to track ovulation.

Detailed technological data will be provided for all specified segments classified in this report.

Infertility Diagnostics Devices Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for infertility diagnostics device patents, having around 11,300 patents. The presence of a well-established healthcare infrastructure, a robust legal framework and prominent research institutions engaged in innovations contributes to the patent landscape significantly.

Holding a significant chunk of the global population, China is another vital jurisdiction and is witnessing rapid growth in patent filings. The expanding healthcare landscape in the region contributes to the evolving research capabilities, thereby influencing a surge in patent applications.

Patent Profile of Key Companies

Among the players with infertility diagnostics device patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field.  Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Genentech Inc

It is a leading biotechnology company committed to create and distribute cutting-edge therapies for a range of illnesses, including infertility. They are renowned for their contributions to diagnostic tools and biopharmaceuticals, which address pressing global health needs.

Abbott Lab

A multinational healthcare corporation well-known for offering a wide variety of medical equipment and diagnostic services, including infertility diagnostic solutions. Their unique reproductive health technologies are designed to offer precise and trustworthy testing to people who want to know more about and control their fertility.

Other companies include CooperSurgical, Inc., Vitrolife AB and Intin Inc., among others.

Reasons to Purchase this Report

The Global Infertility Diagnostics Devices Patent Report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and also makes it understandable which companies have important patents in this field of infertility diagnostics devices. 

• Innovation Insights: The patent analysis reveals new innovations and technologies in infertility diagnostics devices industry.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry.

• Risk Assessment: In technology-intensive fields such as pumps for microfluidic devices, risks of IP infringement are common. Analysing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

• Legal and Regulatory Compliance: Understanding the patent landscape is critical to ensuring compliance with patent laws and regulations. It helps stakeholders navigate license agreements, avoid infringement lawsuits, and effectively use IP assets in a global marketplace.

Key Questions Answered in the Global Infertility Diagnostics Devices Patent Landscape Report 

• Who are the key players in the infertility diagnostics devices patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in infertility diagnostics device patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the infertility diagnostics devices industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in infertility diagnostics devices?
• What are the challenges and opportunities in the infertility diagnostics devices patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in infertility diagnostic devices?

Related Reports

Global Infertility Treatment Devices Market

Global Infertility Drugs Market

Global Female Dysfunction Treatment Market

Global Sex Reassignment Surgery Market

Global Sexually Transmitted Diseases Testing Market